{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:05:06Z","timestamp":1775581506939,"version":"3.50.1"},"reference-count":23,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>While immune thrombocytopenia often presents with mild bleeding manifestations or surprising findings of thrombocytopenia on routine complete blood counts in patients without symptoms, some patients can present with new thrombocytopenia and life-threatening bleeding. Emergent assessment and treatment are needed to prevent substantial morbidity and even mortality. These patients present to the emergency room with bleeding, and hematologists are subsequently consulted. Understanding the approach to making the diagnosis and excluding other life-threatening illnesses is essential, as is rapid initiation of treatment in the bleeding patient even when the diagnosis of immune- mediated thrombocytopenia is tentative. Using a case-based format, we review how to approach and treat patients presenting with new thrombocytopenia and bleeding.<\/jats:p>","DOI":"10.1182\/hematology.2023000478","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:08:58Z","timestamp":1702048138000},"page":"254-258","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["How to manage ITP with life-threatening bleeding"],"prefix":"10.1182","volume":"2023","author":[{"given":"Jean M.","family":"Connors","sequence":"first","affiliation":[{"name":"1 Division of Hematology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Fein","sequence":"additional","affiliation":[{"name":"2 Heme On Call, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"3","key":"2023120815055299700_hem2023000478C1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2023120815055299700_hem2023000478C2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9","key":"2023120815055299700_hem2023000478C3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa065066","article-title":"Vancomycin-induced immune thrombocytopenia","volume":"356","author":"Von Drygalski","year":"2007","journal-title":"N Engl J Med"},{"issue":"50","key":"2023120815055299700_hem2023000478C4","doi-asserted-by":"crossref","first-page":"e5565","DOI":"10.1097\/MD.0000000000005565","article-title":"Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: a retrospective study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"2023120815055299700_hem2023000478C5","first-page":"37","article-title":"Immature platelet fraction (IPF): a reliable tool to predict peripheral thrombocytopenia","volume":"68","author":"Van De Wyngaert","year":"2020","journal-title":"Curr Res Transl Med"},{"issue":"June","key":"2023120815055299700_hem2023000478C6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2021.03.023","article-title":"Diagnostic characteristics of immature platelet fraction for the assessment of immune thrombocytopenia","volume":"202","author":"Pereira","year":"2021","journal-title":"Thromb Res"},{"issue":"8","key":"2023120815055299700_hem2023000478C7","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/jth.15368","article-title":"Definition of a critical bleed in patients with immune thrombocytopenia: communication from the ISTH SSC subcommittee on platelet immunology","volume":"19","author":"Sirotich","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"23","key":"2023120815055299700_hem2023000478C8","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"11","key":"2023120815055299700_hem2023000478C9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00277-017-3095-6","article-title":"Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients","volume":"96","author":"Tsuda","year":"2017","journal-title":"Ann Hematol"},{"issue":"05","key":"2023120815055299700_hem2023000478C10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1160\/TH08-06-0418","article-title":"Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia","volume":"100","author":"Salama","year":"2008","journal-title":"Thromb Haemost"},{"issue":"6","key":"2023120815055299700_hem2023000478C11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/0003-4819-104-6-808","article-title":"Urgent treatment of idiopathic thrombocytopenic purpura with single-dose gammaglobulin infusion followed by platelet transfusion","volume":"104","author":"Baumann","year":"1986","journal-title":"Ann Intern Med"},{"issue":"3","key":"2023120815055299700_hem2023000478C12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2141.2001.03136.x","article-title":"IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity: prevention of murine thrombocytopenia by IVIg","volume":"115","author":"Crow","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"2023120815055299700_hem2023000478C13","doi-asserted-by":"crossref","first-page":"s27","DOI":"10.1002\/j.1875-9114.1987.tb03510.x","article-title":"Intravenous immune globulin: dosage and administration","volume":"7","author":"Wordell","year":"1987","journal-title":"Pharmacother: J Hum Pharmacol Drug Ther"},{"issue":"8","key":"2023120815055299700_hem2023000478C14","doi-asserted-by":"crossref","first-page":"E327","DOI":"10.1002\/ajh.24404","article-title":"Difficulties in establishing the diagnosis of immune thrombocytopenia: an agreement study","volume":"91","author":"Salib","year":"2016","journal-title":"Am J Hematol"},{"issue":"10","key":"2023120815055299700_hem2023000478C15","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol"},{"issue":"14","key":"2023120815055299700_hem2023000478C16","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2009-07-229815","article-title":"Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia","volume":"115","author":"Zaja","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2023120815055299700_hem2023000478C17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.2021013411","article-title":"SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP","volume":"139","author":"Lee","year":"2022","journal-title":"Blood"},{"issue":"10","key":"2023120815055299700_hem2023000478C18","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/blood-2007-01-065763","article-title":"Boruchov, Sri Gururangan, M. Catherine Driscoll, James B. Bussel. Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)","volume":"110","author":"Donna","year":"2007","journal-title":"Blood"},{"issue":"10241","key":"2023120815055299700_hem2023000478C19","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","author":"HALT-IT Trial Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"10135","key":"2023120815055299700_hem2023000478C20","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"17","key":"2023120815055299700_hem2023000478C21","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic acid for the prevention of blood loss after cesarean delivery","volume":"384","author":"Sentilhes","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"2023120815055299700_hem2023000478C22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood.2022016308","article-title":"Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial","volume":"140","author":"Gernsheimer","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2023120815055299700_hem2023000478C23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00101-021-00939-2","article-title":"Management des blutenden Patienten mit Immunthrombozytopenie [Emergency treatment of severe bleeding in immune thrombocytopenia]","volume":"70","author":"Meyer","year":"2021","journal-title":"Anaesthesist"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/254\/2175826\/254fein.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/254\/2175826\/254fein.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:09:12Z","timestamp":1702048152000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2023\/1\/254\/506436\/How-to-manage-ITP-with-life-threatening-bleeding"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,8]]},"published-print":{"date-parts":[[2023,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2023000478","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,8]]},"published":{"date-parts":[[2023,12,8]]}}}